SK3 Group, Inc. Retains Research and IR Firm Rubicon Capital Advisors

medicalgreenslogoMIAMI, FL–(Marketwired – Jul 24, 2013) –  SK3 Group, Inc. (PINKSHEETS: SKTO) announced today that it has engaged the International firm Rubicon Capital Advisors LLC to advise SK3 and its subsidiary, Medical Greens, Inc. on all matters concerning shareholder and investor awareness for a period of 6 months. Rubicon specializes in overseeing the investor relations for micro-mid cap listed entities looking to raise capital in alternative markets. Rubicon’s CEO said, “It has been with great interest that we have followed the SKTO story and feel that our expertise and proper timing can bring enormous, long-term shareholder value in the weeks and months to come.” “We are pleased to have them join us at this juncture. They are an experienced investor relations firm and we are lucky to have them aboard as we continue to build out our operations and reach,” said Jeffrey Benz, General Counsel and Executive Vice President of Business, Legal, and Government Affairs.

About SK3
SK3 is a healthcare logistics and fulfillment consultancy focused on the delivery of alternative care and medicine. With seasoned management, breakthrough technology and best practices, SK3 brings standardization and transparency to this rapidly growing segment of the alternative care field. For more please visit

About Rubicon Capital Advisors

Rubicon Capital Advisors was founded and is managed by a team that has been actively involved in the financial research and investor relations industry for over 18 years and whose principles have distinguished careers in each of the sectors its covers. For more on Rubicon,

Safe Harbor Statement

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements are based on the current plans and expectations of management and are subject to a number of uncertainties and risks that could significantly affect the company’s current plans and expectations, as well as future results of operations and financial condition. A more extensive listing of risks and factors that may affect the company’s business prospects and cause actual results to differ materially from those described in the forward-looking statements can be found in the reports and other documents filed by the company with the Securities and Exchange Commission. The company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.


Tags: , , ,